Researcher
Simon De Meyer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Responsible
From1 Aug 2015 → Today - Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Member
From1 Jan 2013 → Today - Biomedical Sciences Group, Kulak Kortrijk Campus (Section)
Member
From1 Oct 2012 → 31 Dec 2012 - Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Oct 2010 → 30 Sep 2012 - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 2001 → 30 Sep 2010
Projects
1 - 10 of 43
- Universal Chimeric Antigen Receptor (UniCAR) T-cell therapy: an innovative treatment for autoimmune diseaseFrom5 Apr 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Universal chimeric antigen receptor (uniCAR)-T cell therapy to treat autoimmune diseases: immune mediated thrombotic thrombocytopenic purpura as a model system.From1 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Endothelium-targeted gene therapy for von Willebrand disease using a hybrid adeno-transposon strategyFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Flow cytometer for the Interdisciplinary Research Facility Life Sciences at Campus Kulak KortrijkFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Towards improved thrombolysis in acute ischemic strokeFrom1 Jan 2021 → 31 Oct 2021Funding: BOF - postdoctoral mandates
- Light sheet microscopy for interdisciplinary research in life sciencesFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Development and validation of a novel platform for fast and easy diagnosis of von Willebrand diseaseFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Towards improved thrombolysis in ischemic stroke exploring novel therapeutic targetsFrom15 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a microfluidic platform for self-governing selection of individual B-cells using bioresponsive hydrogels: a source of fully human therapeutic antibodiesFrom20 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Thrombosis in COVID-19:dysregulation of the tromboinflammatory VWF/ADAMTS13 axis?From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
Publications
31 - 40 of 141
- Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen(2020)
Authors: Charlotte Dekimpe, Elien Roose, Claudia Tersteeg, Sara Horta, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 985 - 990 - Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function(2020)
Authors: Elien Roose, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 1072 - 1080 - Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis(2020)
Authors: Marijke Peetermans, Severien Meyers, Laurens Liesenborghs, Karen Vanhoorelbeke, Simon De Meyer, Christophe Vandenbriele, Marc Hoylaerts, Kim Martinod, Marc Jacquemin, Thomas Vanassche, et al.
Pages: 722 - 731 - Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance(2020)
Authors: Senna Staessens, Frederik Denorme, Hans Deckmyn, Karen Vanhoorelbeke, Simon De Meyer
Pages: 498 - 507 - von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke(2019)
Authors: Frederik Denorme, Karen Vanhoorelbeke, Simon De Meyer
- Release of endothelial activation markers in lungs of patients with malaria-associated acute respiratory distress syndrome(2019)
Authors: Thao-Thy Pham, Simon De Meyer, Philippe Van den Steen
- Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center(2019)
Authors: Shannen Deconinck, Claudia Tersteeg, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 77 - 80 - von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome(2019)
Authors: Sirima Kraisin, Kim Martinod, Claudia Tersteeg, Hans Deckmyn, Karen Vanhoorelbeke, Philippe Van den Steen, Simon De Meyer
Pages: 1372 - 1383 - 14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions(2019)
Authors: Simon De Meyer
Pages: 439 - 441 - Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients(2019)
Authors: Elien Roose, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 1268 - 1276
Patents
1 - 5 of 5
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)